Molecular Model of Imatinib

Molecular Model of Imatinib

C017/6434 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 14.9MB

Downloadable file size: 520.8KB

Price image Pricing

Please login to use the price calculator


Caption: Molecular model of Imatinib (C29 H31 N7 O). Imatinib is part of a new class of drugs used in the treatment of chronic myelogenous leukaemia (CML), gastrointestinal stromal tumours (GIST) and a number of other malignancies. It acts by specifically inhibiting an enzyme (a receptor tyrosine kinase) that is characteristic of a particular cancer cell, rather than non-specifically inhibiting and killing all rapidly dividing cells. Carbon in grey; Hydrogen in white; Nitrogen in blue; Oxygen in red. Mol. mass: 493.603 g/mol.

Release details: Model release not required. Property release not required.

Keywords: c29 h31 n7 o, cancer treatment, carbon, chemistry, cml treatment, drugs, gastrointestinal stromal, gist, gleevec, glivec, hydrogen, imatinib, malignancies, malignancy, medicines, model, modelling, molecular, molecular structure, molecules, myelogenous leukaemia treatment, nitrogen, oxygen, tumours, tyrosine kinase, tyrosine-kinase inhibitor

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.